Olon S.p.A., an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has purchased a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint. “By acquiring a manufacturing base in India, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop new generic products for the Indian market,” said Pao...